Soluble Fas ligand is another good diagnostic marker for tuberculous pleurisy

Diagnostic Microbiology and Infectious Disease

Volumn 68, Issue 4, 2010, Pages 395-400

  Wu, Shin Hwar ^a,b   Li, Chien Te ^b   Lin, Ching Hsiung ^b   Chu, Jao Jia ^c   Cheng, Min Lin ^b   Lin, Kai Huang ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Adenosine deaminase; Diagnosis; Fas ligand; Interferon ?; Tuberculous pleurisy

Indexed keywords

ADENOSINE DEAMINASE; FAS LIGAND; GAMMA INTERFERON;

AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PLEURA EFFUSION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; TUBERCULOUS PLEURISY;

ADENOSINE DEAMINASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FAS LIGAND PROTEIN; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; PLEURAL EFFUSION; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, PLEURAL;

EID: 78649320357     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.08.008     Document Type: Article

References (39)

1. Antony V.B., Sahn S.A., Antony A.C., Repine J.E. Bacillus Calmette-Guerin-stimulated neutrophils release chemotaxins for monocytes in rabbit pleural spaces and in vitro. J Clin Invest 1985, 76:1514-1521.
2. Aoki K., Kurooka M., Chen J.J., Petryniak J., Nabel E.G., Nabel G.J. Extracellular matrix interacts with soluble CD95L: retention and enhancement of cytotoxicity. Nat Immunol 2001, 2:333-337.
3. Baumann M.H., Nolan R., Petrini M., Lee Y.C.G., Light R.W., Schneider E. Pleural tuberculosis in the United States: incidence and drug resistance. Chest 2007, 131:1125-1132.
4. Boselli D., Losana G., Bernabei P., Bosisio D., Drysdale P., Kiessling R., Gaston J.S., Lammas D., Casanova J.L., Kumararatne D.S., Novelli F. IFN-gamma regulates Fas ligand expression in human CD4+ T lymphocytes and controls their anti-mycobacterial cytotoxic functions. Eur J Immunol 2007, 37:2196-2204.
5. Budak F., Uzaslan E.K., Cangur S., Goral G., Oral H.B. Increased pleural soluble fas ligand (sFasL) levels in tuberculosis pleurisy and its relation with T-helper type 1 cytokines. Lung 2008, 186:337-343.
6. Burgess L.J., Maritz F.J., Le Roux I., Taljaard J.J. Use of adenosine deaminase as a diagnostic tool for tuberculous pleurisy. Thorax 1995, 50:672-674.
7. Celik G., Kaya A., Poyraz B., Ciledag A., Elhan A.H., Oktem A., Tozkoparan E., Ozkan M. Diagnostic value of leptin in tuberculous pleural effusions. Int J Clin Pract 2006, 60:1437-1442.
8. Chen M.L., Yu W.C., Lam C.W., Au K.M., Kong F.Y., Chan A.Y.W. Diagnostic value of pleural fluid adenosine deaminase activity in tuberculous pleurisy. Clinica Chimica Acta 2004, 341:101-107.
9. Chierakul N., Damrongchokpipat P., Chaiprasert A., Arjratanakul W. Antibody detection for the diagnosis of tuberculous pleuritis. Int J Tuberc Lung Dis 2001, 5:968-972.
10. Cok G., Parildar Z., Basol G., Kabaroglu C., Bayindir U., Habif S., Bayindir O. Pleural fluid neopterin levels in tuberculous pleurisy. Clin Biochem 2007, 40:876-880.
11. Dheda K., Van-Zyl Smit R.N., Sechi L.A., Badri M., Meldau R., Symons G., Khalfey H., Carr I., Maredza A., Dawson R., Wainright H., Whitelaw A., Bateman E.D., Zumla A. Clinical diagnostic utility of IP-10 and LAM antigen levels for the diagnosis of tuberculous pleural effusions in a high burden setting. PLoS One 2009, 4:e4689.
12. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995, 270:1189-1192.
13. Hara N., Abe M., Inuzuka S., Kawarada Y., Shigematsu N. Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions. Chest 1992, 102:1060-1064.
14. Hooper C.E., Lee Y.C., Maskell N.A. Interferon-gamma release assays for the diagnosis of TB pleural effusions: hype or real hope?. Curr Opin Pulm Med 2009, 15:358-365.
15. Ipcioglu O.M., Ozcan O., Gultepe M., Deniz O., Akgul E.O. Prolidase activity in serum and pleural fluids in patients with tuberculous pleural effusion. Clinical Biochemistry 2008, 41:670-675.
16. Jiang J., Shi H.Z., Liang Q.L., Qin S.M., Qin X.J. Diagnostic value of interferon-gamma in tuberculous pleurisy: a metaanalysis. Chest 2007, 131:1133-1141.
17. Lenth R. Java Applets for power and sample size [computer software]. Retrieved Feb, 15, 2010, from. http://www.stat.uiowa.edu/~rlenth/Power.
18. Lettau M., Paulsen M., Kabelitz D., Janssen O. Storage, expression and function of Fas ligand, the key death factor of immune cells. Curr Med Chem 2008, 15:1684-1696.
19. Liam C.K., Lim K.H., Wong C.M. Causes of pleural exudates in a region with a high incidence of tuberculosis. Respirology 2000, 5:33-38.
20. Liang Q.L., Shi H.Z., Wang K., Qin S.M., Qin X.J. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respiratory Medicine 2008, 102:744-754.
21. Light R. Pleural diseases 2001, 182-195. Lippincott Williams and Wilkins, Philadelphia, PA. 4th ed.
22. Light R.W., Macgregor M.I., Luchsinger P.C., Ball W.C. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972, 77:507-513.
23. Murphy K., Travers P., Walport M. T cell-mediated immunity. Janeway's immunobiology 2008, 369-372. Garland Science, New York, NY. 7th ed.
24. Mustafa T., Phyu S., Nilsen R., Bjune G., Jonsson R. Increased expression of Fas ligand on Mycobacterium tuberculosis infected macrophages: a potential novel mechanism of immune evasion by Mycobacterium tuberculosis?. Inflammation 1999, 23:507-521.
25. Nagata S. Apoptosis by death factor. Cell 1997, 88:355-365.
26. O' Reilly L.A., Tai L., Lee L., Kruse E.A., Grabow S., Fairlie W.D., Haynes N.M., Tarlinton D.M., Zhang J.G., Belz G.T., Smyth M.J., Bouillet P., Robb L., Strasser A. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature 2009, 461:659-663.
27. Oddo M., Renno T., Attinger A., Bakker T., MacDonald H.R., Meylan P.R.A. Fas Ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol 1998, 160:5448-5454.
28. Ottonello L., Tortolina G., Amelotti M., Dallegri F. Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes. J Immunol 1999, 162:3601-3606.
29. Pai M., Flores L.L., Hubbard A., Riley L.W., Colford J.M. Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and meta-analysis. BMC Infect Dis 2004, 4:6.
30. Rios-Barrera V.A., Campos-Pena V., Aguilar-Leon D., Lascurain L.R., Meraz-Rios M.A., Moreno J., Figueroa-Granados V., Hernandez-Pando R. Macrophage and T lymphocyte apoptosis during experimental pulmonary tuberculosis: their relationship to mycobacterial virulence. Eur J Immunol 2006, 36:345-353.
31. Schneider P., Holler N., Bodmer J.L., Hahne M., Frei K., Fontana A., Tschopp J. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 1998, 187:1205-1213.
32. Shibagaki T., Hasegawa Y., Saito H., Yamori S., Shimokata K. Adenosine deaminase isozymes in tuberculous pleural effusion. J Lab Clin Med 1996, 127:348-352.
33. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993, 75:1169-1178.
34. Tanaka M., Itai T., Adachi M., Nagata S. Downregulation of Fas ligand by shedding. Nat Med 1998, 4:31-36.
35. Trajman A., Pai M., Dheda K., van Zyl Smit R., Zwerling A.A., Joshi R., Kalantri S., Daley P., Menzies D. Novel tests for diagnosing tuberculous pleural effusion: what works and what does not?. Eur Respir J 2008, 31:1098-1106.
36. Valdes L., Alvarez D., San Jose E., Penela P., Valle J.M., Garcia-Pazos J.M., Suarez J., Pose A. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med 1998, 158:2017-2021.
37. Villena V., Lopez-Encuentra A., Pozo F., Echave-Sustaeta J., Ortuno-de-Solo B., Estenoz-Alfaro J., Martin-Escribano P. Interferon gamma levels in pleural fluid for the diagnosis of tuberculosis. Am J Med 2003, 115:365-370.
38. Wang P.S., Chen Y.M., Hsieh Y.L., Yu C.F., Tsai C.M., Perng R.P. Pleural effusion and serum soluble fas-ligand levels are elevated in different clinical conditions. Lung 2002, 180:25-32.
39. Wu S.H., Chu J.J., Chiang C.D. Increased soluble Fas ligand concentration in tuberculous pleural effusion. J Formos Med Assoc 2001, 100:32-34.